Exscientia PLC (EXAI)
4.95
+0.25
(+5.32%)
USD |
NASDAQ |
May 22, 16:00
5.08
+0.13
(+2.63%)
Pre-Market: 08:00
Exscientia Shareholders Equity (Quarterly): 302.35M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 302.35M |
| December 31, 2023 | 453.16M |
| September 30, 2023 | 479.47M |
| June 30, 2023 | 526.31M |
| March 31, 2023 | 554.51M |
| December 31, 2022 | 579.54M |
| September 30, 2022 | 570.66M |
| Date | Value |
|---|---|
| June 30, 2022 | 649.00M |
| March 31, 2022 | 726.57M |
| December 31, 2021 | 764.99M |
| September 30, 2021 | 313.74M |
| June 30, 2021 | 305.92M |
| December 31, 2020 | 79.76M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
79.76M
Minimum
Dec 2020
764.99M
Maximum
Dec 2021
485.07M
Average
526.31M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Akero Therapeutics Inc | 846.25M |
| AstraZeneca PLC | 37.44B |
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| Verona Pharma PLC | 224.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 597.86M |
| Total Liabilities (Quarterly) | 180.49M |
| Current Ratio | 6.296 |
| Net Debt Paydown Yield | 0.01% |